Ansprechpartner

Sandra Dittmann

Sales & Customer Service SEND E-MAIL

Kategorie

Antibodies/Antigens

Keywords

hybridoma development
immunization
mouse monoclonal antibodies

Mouse Hybridoma Development

InVivo BioTech Services GmbH

With passion and know-how, InVivo has successfully realized more than 500 hybridoma development projects to date. The entire project, including mice immunization, cell fusion, screening, cloning and initial characterization of the developed monoclonal antibodies, usually takes around 22 weeks. For immunization ~ 5 mg of antigen (protein, peptide or hapten) is needed. In case the antigen (protein) is not available yet, InVivo can produce the protein of interest via expression in E. coli or via transient gene expression in HEK cells.

Vorteile des Produkts

  • Individualized screening
  • Negative screening to avoid cross-reactions
  • Isotyping and mycoplasma test

Downloads

Mouse Hybridoma Development

Ähnliche Produkte

Contract Manufacturing, monoclonal antibodies, Proteins

Antibodies/Antigens, Substrates/Particles

Contract Manufacturing Monoclonal Antibodies, Native & Recombinant Proteins

Latex kits

Antibodies/Antigens, Immunochemistry, Indication

Febrile Antigen kits

Antibodies/Antigens, Indication